World's Best Scientists 2026 revealed!
Isabelle Sermet-Gaudelus

Isabelle Sermet-Gaudelus

D-Index & Metrics

Molecular Biology

D-Index
59
Citations
15904
World Ranking
2006
National Ranking
70

Isabelle Sermet-Gaudelus publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Isabelle Sermet-Gaudelus sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 202 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Isabelle Sermet-Gaudelus D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Isabelle Sermet-Gaudelus sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 59 D-Index — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Isabelle Sermet-Gaudelus is affiliated with Necker-Enfants Malades Hospital in France and has contributed extensively to the field of medicine, focusing primarily on pulmonary and respiratory medicine. Their research spans multiple subfields including molecular biology, infectious diseases, epidemiology, and genetics, with a particular emphasis on cystic fibrosis and respiratory disorders in pediatric populations.

The scientist's publication record includes over 335 works in medicine, with significant contributions to journals such as the Journal of Cystic Fibrosis, where they have published 81 papers, bioRxiv (Cold Spring Harbor Laboratory) with 12 publications, and the European Respiratory Journal featuring 7 articles. Other frequent venues include The Lancet Respiratory Medicine and the International Journal of Molecular Sciences.

Research topics most commonly addressed by Isabelle Sermet-Gaudelus include:

  • Cystic Fibrosis Research Advances
  • Neonatal Respiratory Health Research
  • Tracheal and airway disorders
  • Pediatric health and respiratory diseases
  • Asthma and respiratory diseases
  • Respiratory viral infections research
  • Inhalation and Respiratory Drug Delivery

Frequent co-authors in their work include Philippe Reix, Iwona Pranke, Alexandre Hinzpeter, Aurélie Hatton, and Pierre-Régis Burgel. These collaborations have contributed to an extensive body of work advancing the understanding and treatment of respiratory and genetic disorders related to cystic fibrosis.

Some recent publications by Isabelle Sermet-Gaudelus include:

  • "Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study," 2020, The Lancet Child & Adolescent Health
  • "Impact of COVID-19 on people with cystic fibrosis," 2020, The Lancet Respiratory Medicine
  • "A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis," 2020, Journal of Cystic Fibrosis
  • "Updated guidance on the management of children with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome/cystic fibrosis screen positive, inconclusive diagnosis (CRMS/CFSPID)," 2020, Journal of Cystic Fibrosis
  • "Airway Surface Liquid pH Regulation in Airway Epithelium Current Understandings and Gaps in Knowledge," 2021, International Journal of Molecular Sciences

Best Publications

  • A CFTR potentiator in patients with cystic fibrosis and the G551D mutation

    Bonnie W. Ramsey;Jane Davies;N. Gerard McElvaney;Elizabeth Tullis

  • Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation

    Philip M. Farrell;Terry B. White;Clement L. Ren;Sarah E. Hempstead

  • SLC34A3 Mutations in Patients with Hereditary Hypophosphatemic Rickets with Hypercalciuria Predict a Key Role for the Sodium-Phosphate Cotransporter NaPi-IIc in Maintaining Phosphate Homeostasis

    Clemens Bergwitz;Nicole M. Roslin;Martin Tieder;J.C. Loredo-Osti

  • US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis

    R. Andres Floto;R. Andres Floto;Kenneth N. Olivier;Lisa Saiman;Charles L. Daley

  • Recommendations for the classification of diseases as CFTR-related disorders

    Cristina Bombieri;M Claustres;K De Boeck;N Derichs

  • Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial

    Eitan Kerem;Michael W Konstan;Kris De Boeck;Frank J Accurso

  • European best practice guidelines for cystic fibrosis neonatal screening

    Carlo Castellani;Kevin W. Southern;Keith Brownlee;Jeannette Dankert Roelse

  • Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis

    Unknown

  • Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST)

    Edward F McKone;Drucy Borowitz;Pavel Drevinek;Matthias Griese;Matthias Griese

  • European cystic fibrosis bone mineralisation guidelines.

    Isabelle Sermet-Gaudelus;Maria Luisa Bianchi;Michèle Garabédian;Robert M. Aris

  • In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study

    Isabelle Sermet-Gaudelus;Isabelle Sermet-Gaudelus;Michel Renouil;Anne Fajac;Laure Bidou;Laure Bidou

  • Age-Related Prevalence and Distribution of Nontuberculous Mycobacterial Species among Patients with Cystic Fibrosis

    Catherine Pierre-Audigier;Agnès Ferroni;Isabelle Sermet-Gaudelus;Muriel Le Bourgeois

  • Mycobacterium abscessus and children with cystic fibrosis.

    Isabelle Sermet-Gaudelus;Muriel Le Bourgeois;Catherine Pierre-Audigier;Catherine Offredo

  • Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.

    Unknown

  • Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity

    Erwan Pernet;Erwan Pernet;Erwan Pernet;Laurent Guillemot;Laurent Guillemot;Pierre-Régis Burgel;Clémence Martin

  • Impact of COVID-19 on people with cystic fibrosis.

    Unknown

  • New clinical diagnostic procedures for cystic fibrosis in Europe

    K. De Boeck;N. Derichs;I. Fajac;H.R. de Jonge

  • Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators

    Iwona M. Pranke;Aurélie Hatton;Juliette Simonin;Jean Philippe Jais

  • Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis

    Unknown

  • The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening

    Thauvin-Robinet C;Munck A;Huet F;Génin E

Frequent Co-Authors

Aleksander Edelman
Aleksander Edelman Université Paris Cité
Patrick Berche
Patrick Berche Université Paris Cité
Jean-Louis Gaillard
Jean-Louis Gaillard Hôpital Ambroise-Paré
Steven M. Rowe
Steven M. Rowe University of Alabama at Birmingham
J. Stuart Elborn
J. Stuart Elborn Queen's University Belfast
Claire E. Wainwright
Claire E. Wainwright University of Queensland
Michael W. Konstan
Michael W. Konstan Case Western Reserve University
Felix Ratjen
Felix Ratjen University of Toronto
Xavier Nassif
Xavier Nassif Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Molecular Biology, related online degrees such as nursing or health sciences can open diverse career pathways. Selecting the best program is essential, especially with the wide range of online options available. Students often compare wgu vs chamberlain to find flexible, reputable RN-to-BSN pathways that fit their personal schedules.

Those pursuing advanced roles may benefit from bsn to msn bridge programs, which offer an accelerated route to specialized positions in research or healthcare management. Choosing a non profit university can provide additional confidence in the program’s accreditation and affordability.

If you’re active military or a veteran, selecting an online college for military ensures additional support and benefits. Ultimately, the right degree pathway can help you build a rewarding career in scientific research, academia, or industry settings related to molecular biology.

Best Scientists Citing Isabelle Sermet-Gaudelus

Trending Scientists

Recently Published Articles